DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
HUMAN GENE THERAPY SUBCOMMITTEE 
MINUTES OF MEETING^ 
November 30, 1990 
The Human Gene Therapy Subcommittee (a subcommittee of the Recombinant 
DNA Advisory Committee) was convened at 9:00 a.m. on November 30, 1990, in 
Building 3 1C, Conference Room 6, National Institutes of Health, 9000 Rockville 
Pike, Bethesda, Maryland 20892. Dr. LeRoy Walters (Chair) presided. In 
accordance with Public Law 92-463, the meeting was open to the public. The 
following were present for all or part of the meeting (a subcommittee roster is 
attached): 
Subcommittee members: 
Alexander M. Capron, University of Southern California 
James F. Childress, University of Virginia 
Charles J. Epstein, University of California, San Francisco 
Robert P. Erickson, University of Arizona 
Martin F. Gellert, National Institutes of Health 
William N. Kelley, University of Pennsylvania 
Maurice J. Mahoney, Yale University 
R. Scott Mclvor, University of Minnesota 
Abbey S. Meyers, National Organization for Rare Disorders 
Robert F. Murray, Howard University 
Robertson Parkman, Childrens Hospital of Los Angeles 
Doris T. Zallen, Virginia Polytechnical Institute & State University 
Liaison Representatives: 
Robert M. Cook-Deegan, Biomedical Ethics Advisory Committee 
Aim Graham, Food and Drug Administration 
Charles McCarthy, National Institutes of Health 
Henry I. Miller, Food and Drug Administration 
^The Human Gene Therapy Subcommittee is advisory to the Recombinant DNA 
Advisory Committee, and its recommendations should not be considered as final 
or accepted. The Office of Recombinant DNA Activities should be consulted for 
NIH policy on specific issues. 
Recombinant DNA Research, Volume 14 
[371] 
